@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP670956.RAuFWg_IvTCnwXmPOS9HSGkQj31ZQl1A6bVej7aNFvp5U130_head { this: np:hasAssertion dgn-np:NP670956.RAuFWg_IvTCnwXmPOS9HSGkQj31ZQl1A6bVej7aNFvp5U130_assertion; np:hasProvenance dgn-np:NP670956.RAuFWg_IvTCnwXmPOS9HSGkQj31ZQl1A6bVej7aNFvp5U130_provenance; np:hasPublicationInfo dgn-np:NP670956.RAuFWg_IvTCnwXmPOS9HSGkQj31ZQl1A6bVej7aNFvp5U130_publicationInfo; a np:Nanopublication . dgn-np:NP670956.RAuFWg_IvTCnwXmPOS9HSGkQj31ZQl1A6bVej7aNFvp5U130_assertion a np:Assertion . dgn-np:NP670956.RAuFWg_IvTCnwXmPOS9HSGkQj31ZQl1A6bVej7aNFvp5U130_provenance a np:Provenance . dgn-np:NP670956.RAuFWg_IvTCnwXmPOS9HSGkQj31ZQl1A6bVej7aNFvp5U130_publicationInfo a np:PublicationInfo . } dgn-np:NP670956.RAuFWg_IvTCnwXmPOS9HSGkQj31ZQl1A6bVej7aNFvp5U130_assertion { miriam-gene:3439 a ncit:C16612 . lld:C0239946 a ncit:C7057 . dgn-gda:DGNec62574c02610e4140e56fecc3e8fff6 sio:SIO_000628 miriam-gene:3439, lld:C0239946; a sio:SIO_001121 . } dgn-np:NP670956.RAuFWg_IvTCnwXmPOS9HSGkQj31ZQl1A6bVej7aNFvp5U130_provenance { dgn-np:NP670956.RAuFWg_IvTCnwXmPOS9HSGkQj31ZQl1A6bVej7aNFvp5U130_assertion dcterms:description "[Patients with a `good treatment profile,` including an early stage of liver fibrosis, a non-1b genotype and serum HCV-RNA <0.35 x 10(6) Eq/mL, had a 66.7% rate of observed virological SR, compared with a zero response for those with the opposite, a `bad treatment profile.` We conclude that a 12-month IFN treatment, along with a non-1b genotype and the absence of advanced stage of fibrosis, are the main determinants for the induction of a virological primary response in chronic hepatitis C. Such response, along with a low pretreatment serum HCV-RNA level, are the main predictors for a 4-year virological response to IFN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:9303505; prov:wasDerivedFrom dgn-void:befree-20140225; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20140225 pav:importedOn "2014-02-25"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP670956.RAuFWg_IvTCnwXmPOS9HSGkQj31ZQl1A6bVej7aNFvp5U130_publicationInfo { this: dcterms:created "2014-10-02T12:38:45+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetrdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v2.1.0.0" . dgn-void:disgenetrdf pav:version "v2.1.0" . }